GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
116 hedge funds and large institutions have $1.38B invested in GW Pharmaceuticals Plc American Depositary Shares in 2016 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 32 increasing their positions, 22 reducing their positions, and 23 closing their positions.
45% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 22
35% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 23
34% more capital invested
Capital invested by funds: $1.03B → $1.38B (+$351M)
7% more funds holding
Funds holding: 108 → 116 (+8)
6% more call options, than puts
Call options by funds: $113M | Put options by funds: $107M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Scopia Capital Management
New York
|
+$124M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$70M |
| 3 |
DM
Deerfield Management
New York
|
+$26.7M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$16M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$13.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$40.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$36.7M |
| 3 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$23.4M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$21.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$19.2M |
GWPH Hedge Fund Activity: Q2 2016 in Review
116 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q2 2016, worth a combined $1.38B — up 34% from $1.03B a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new GWPH positions and 23 closed out — a net gain of 8 holders — while 32 added to existing stakes and 22 trimmed.
The largest buyer was Scopia Capital Management, opening a new position worth an estimated $124M. The largest seller was Millennium Management, cutting an estimated $40.2M.
- 116 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q2 2016, up from 108 in Q1 2016.
- Funds reported $1.38B of GW Pharmaceuticals Plc American Depositary Shares stock for Q2 2016, up 34% quarter-over-quarter.
- 31 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q2 2016 and 23 closed out, a net change of +8 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q2 2016 was Scopia Capital Management, an estimated $124M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q2 2016 was Millennium Management, an estimated $40.2M sold.
Based on aggregated 13F filings for Q2 2016.